| ID Source | ID |
|---|---|
| PubMed CID | 180933 |
| CHEMBL ID | 421215 |
| CHEBI ID | 94533 |
| SCHEMBL ID | 893374 |
| Synonym |
|---|
| PRESTWICK3_000615 |
| chrysene-1,4-quinone |
| PRESTWICK_898 |
| cas-100900-16-1 |
| NCGC00016967-01 |
| BSPBIO_000550 |
| PRESTWICK2_000615 |
| BPBIO1_000606 |
| chrysene-1,4-dione |
| PRESTWICK0_000615 |
| PRESTWICK1_000615 |
| SPBIO_002769 |
| NCGC00016967-02 |
| C2214 |
| 1,4-chrysenequinone |
| 100900-16-1 |
| 1-4-chrysenequinone |
| CHEMBL421215 , |
| bdbm50107004 |
| HMS1569L12 |
| 1,4-chrysenedione |
| HMS2096L12 |
| FT-0642436 |
| BRD-K18812295-001-01-5 |
| SCHEMBL893374 |
| mfcd00009941 |
| UORKIKBNUWJNJF-UHFFFAOYSA-N |
| 1,4-chrysenedione # |
| DTXSID90143571 |
| J-000250 |
| SR-01000872668-1 |
| sr-01000872668 |
| AKOS027320075 |
| CHEBI:94533 |
| CS-0040835 |
| HY-111441 |
| Q27166376 |
| D89496 |
| GLXC-26778 |
| 1,4-dihydrochrysene-1,4-dione |
| Class | Description |
|---|---|
| phenanthrenes | Any benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 14.0919 | 0.1409 | 11.1940 | 39.8107 | AID2451 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 3.5481 | 0.1413 | 37.9142 | 100.0000 | AID1490 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 35.4813 | 0.0316 | 37.5844 | 354.8130 | AID504865 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 0.3162 | 0.0112 | 12.4002 | 100.0000 | AID1030; AID493210 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 7.9433 | 0.0013 | 7.7625 | 44.6684 | AID914; AID915 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 5.0119 | 0.0355 | 20.9770 | 89.1251 | AID504332 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 5.0119 | 0.0020 | 7.5337 | 39.8107 | AID891 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 10.0000 | 0.3162 | 12.4435 | 31.6228 | AID924 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 15.8489 | 1.0000 | 12.2326 | 31.6228 | AID1452 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 1.5849 | 0.0025 | 5.8400 | 31.6228 | AID899 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 1.2589 | 0.0063 | 6.9043 | 39.8107 | AID883 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 11.2202 | 0.0018 | 15.6638 | 39.8107 | AID894 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 3.1623 | 0.3548 | 28.0659 | 89.1251 | AID504847 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 12.5893 | 0.0398 | 16.7842 | 39.8107 | AID995 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 3.1623 | 0.6561 | 9.4520 | 25.1189 | AID927 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 14.1254 | 0.0079 | 8.2332 | 1,122.0200 | AID2546; AID2551 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 5.0119 | 0.8913 | 12.0676 | 28.1838 | AID1487 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 2.5119 | 0.3162 | 12.7657 | 31.6228 | AID881 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 10.0000 | 0.3162 | 11.4157 | 31.6228 | AID924 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 10.0000 | 0.3162 | 11.4157 | 31.6228 | AID924 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 1.7601 | 0.0063 | 8.2350 | 39.8107 | AID881; AID883 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 3.1623 | 1.5849 | 13.0043 | 25.1189 | AID927 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Papain | Carica papaya (papaya) | IC50 (µMol) | 18.0000 | 0.0020 | 1.5045 | 10.0000 | AID155386 |
| Genome polyprotein | Human rhinovirus sp. | IC50 (µMol) | 46.5000 | 0.0005 | 2.9838 | 8.2000 | AID163631 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID155386 | Inhibitory activity against papain using HPLC assay | 2001 | Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24 | Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. |
| AID163631 | Inhibitory activity against HRV 3Cpro using HPLC assay | 2001 | Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24 | Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. |
| AID224910 | Percent inhibition against papain | 2001 | Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24 | Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||